Does PALBOCICLIB Cause Metastases to liver? 525 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 525 reports of Metastases to liver have been filed in association with PALBOCICLIB (Ibrance). This represents 0.6% of all adverse event reports for PALBOCICLIB.
525
Reports of Metastases to liver with PALBOCICLIB
0.6%
of all PALBOCICLIB reports
70
Deaths
67
Hospitalizations
How Dangerous Is Metastases to liver From PALBOCICLIB?
Of the 525 reports, 70 (13.3%) resulted in death, 67 (12.8%) required hospitalization, and 19 (3.6%) were considered life-threatening.
Is Metastases to liver Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 525 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Metastases to liver?
LETROZOLE (1,295)
FULVESTRANT (1,241)
CAPECITABINE (1,061)
EVEROLIMUS (1,020)
RIBOCICLIB (967)
PACLITAXEL (885)
OCTREOTIDE (774)
BEVACIZUMAB (707)
FLUOROURACIL (630)
TAMOXIFEN (595)
Which PALBOCICLIB Alternatives Have Lower Metastases to liver Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID